Many rodent renal and bladder carcinogens rely upon epigenetic mechanisms of carcinogenesis ; such mechanisms are likely to in uence the spectrum of urinary tract tumors observed in control and treated animals. This is re ected in several features of chemically induced rodent urinary tract neoplasms, including a low overall tumor incidence, an increased prevalence of urinary tract tumors in rats compared to mice and males compared to females, the tendency for epithelial tumors to predominate over nonepithelial types, and demonstrated links to chronic progressive nephropath y and urolithiasis. Such tendencies are also characteristic of spontaneous urinary tract tumors in rodents. Data to support these observations can be derived from large historical databases such as the Toxicology Data Management System, maintained by National Toxicology Program.
INTRODUCTION
From 1990 to 1996, tumors of the kidney, renal pelvis, and urinary bladder were reported to occur in approximately 25 of every 100,000 persons in the United States, and were associated with the deaths of approximately 7 of every 100,000 persons (1) . In the United States, bladder cancer is the fth most common human malignancy (2) . Epidemiological evidence has implicated certain substances (eg, cigarette smoke, analgesic abuse, aniline dyes) as causative factors in the pathogenesis of kidney and/or urinary bladder neoplasms (3, 4) . Based upon results of rodent carcinogenicity studies, it is likely that further exogenous risk factors for human urinary tract tumors have yet to be de ned (5) .
Risk assessment decisions that pertain to environmental issues and human health are frequently based on the results obtained from rodent carcinogenicity studies. Insight into the mechanisms of comparative carcinogenesis in rodents and humans may be gained by periodically monitoring large historical databases for tumor incidences and trends. The National Toxicology Program/National Institute of Environmental Health Sciences (NTP/NIEHS) maintains a computerized data bank, the Toxicology Data Management System (TDMS), comprised of tumor incidences compiled from the NTP's 2-year carcinogenesis studies. The TDMS incorporates 5 to 7 years' worth of data from peer-reviewed studies in which Fischer 344/N (F344) rats or B6C3F 1 mice were utilized (6) (7) (8) .
Since the early 1970s, F344 inbred rats and B6C3F 1 hybrid mice have been the standard strains used in the National Cancer Institute Bioassay Program, and in toxicity and carcinogenicity studies of the NTP/NIEHS. Both rodent strains are genetically stable, phenotypically uniform, relatively long-lived, sensitive to a wide variety of carcinogens and tend to produce fewer spontaneous tumors compared to other strains (9, 10) . Although a 74% concordance of results has been demonstrated between F344 rats and B6C3F 1 mice in carcinogenicity studies (11) , the relevance of these results to human health risk are often less clear (12) .
POTENTIAL FACTORS IN RODENT URINARY TRACT
CARCINOGENESIS There are several features of the rodent urinary tract (UT) that may in uence the spectrum and relative incidence of local tumor development. The kidney possesses enzyme systems for both Phase I and Phase II xenobiotic transformation reactions (13) . Cytochrome P-450 levels in the kidney are approximately 20% those of the liver (14) . Consequently, electrophilic substances produced by metabolic transformation may become concentrated in the kidney, potentially promoting DNA adduct formation (15) . Another characteristic of the rodent kidney is a relatively high incidence of chronic progressive nephropathy (CPN), a spontaneously developing degenerative disease that is observed primarily in older individuals (especially male rats). Theoretically, the increased cell turnover that accompanies CPN could increase the probability for error during DNA replication, decrease the opportunity for DNA repair of such errors, and provide a stimulus for the clonal proliferation of mutated cells (15) (16) (17) . It has been suggested that at least 1 chemical (hydroquinone) may exert its tumorigenic effects upon the kidney via enhancement of CPN (15, 18, 19) . A phenomenon that appears to be entirely restricted to the male rat kidney (excluding androgenized female rats and some genetically altered mice) is the ability of certain chemicals (eg, D-limonene, unleaded gasoline) to cause renal tumors via a 2u -globulin nephropathy (16, 20) .
For the urinary bladder, urine stasis is a potential carcinogenesis factor. Not only does urine provide an effective storage and transport medium for carcinogens that are eliminated through the urinary tract (21), both human and rodent urine are known to contain growth factors (eg, epidermal growth 657 0192-6233/02$3.00 $0.00 WOLF TOXICOLOGIC PATHOLOGY factor, transferrin) that can stimulate urothelial cell proliferation and consequently tumorigenesis (22) (23) (24) (25) . One carcinogenic mechanism that may or may not be unique to rodents is the well-documented association of bladder tumor formation with the presence of uroliths, microcrystalluria, and urine precipitates (26, 27, 28) .
SPONTANEOUS UT TUMORS IN F344 RATS AND B6C3F 1 MICE The rodent urinary tract appears to be an uncommon site for spontaneous tumor formation. Compared to other organs, the incidences of tumors in the kidney and bladder have been ranked as high as 10th (renal tumors in male mice) and as low as18th (bladder tumors in male rats) (29) . In order to document the incidence of spontaneous urinary tract tumors in F344 rats and B6C3F 1 mice, data was compiled from 46 studies in the TDMS database ("NTP Historical Control Information 2000" data available at <http://ehis.niehs.nih.gov / ntp/docs/ntp hcrs.html>, last updated 2/24/00). Speci cally, the data was screened to include male and female negative control animals from chronic (2-year) inhalation, feed and water studies. Studies in which animals were exposed to a delivery vehicle (eg, corn oil) or extensively manipulated (eg, gavage studies) were excluded.
Spontaneous, primary tumors were present in 80 of the 18,824 (0.42%) kidney and urinary bladder tissues examined (Table 1) (30) . No spontaneous ureteral or urethral tumors were recorded for F344 rats and B6C3F 1 mice from the selected studies. The incidence of urinary tract tumors was 0.59% for F344 rats and 0.26% for B6C3F 1 mice. These gures are essentially consistent with previously reported incidences (< 1%) for UT tumors in F344 rats and B6C3F 1 mice (29, 31) . Although UT tumors appear to occur more frequently in other rat and mouse strains (Sprague-Dawley and Wistar rats, CD-1 mice), the incidence of such neoplasms is generally reported to be < 2% (29) . In F344 rats from the selected studies, UT tumors were more than twice as common in males compared to females (0.84% vs 0.34%), primarily due to the relatively high number of renal adenomas diagnosed in the male mice. In B6C3F 1 mice, there were almost 3 times as many tumors in males (0.38% vs 0.13%), due in part to the complete lack of bladder tumors observed in the female mice. For rats, kidney tumors outnumbered bladder tumors by greater than 4:1 (0.95% vs 0.23%), and in mice this ratio was greater than 2:1 (0.36% vs 0.15%). Overall, the most common site for urinary tract tumor formation was the male rat kidney (1.34%) and the least common site was the female mouse bladder (0.00%).
Categories and speci c types of urinary tract neoplasms encountered in the selected studies are listed (Tables 2 and  3 ). For the F344 rats, 82.1% of the tumors were epithelial types (papillomas, adenomas, carcinomas, oncocytomas), vs tumors of mesenchymal or embryonal tissue origin (Table 4 ). In B6C3F 1 mice, 62.5% of the tumors were epithelial. Of the urinary tract neoplasms identi ed in F344 rats, 71.4% were given benign diagnoses (or were of tumor types generally considered to be benign), whereas in B6C3F 1 mice this gure was 58.3% ( Table 5 ). The renal tubular adenoma of the male rat was the single most common urinary tract tumor in the selected studies (0.97% incidence in male rats). Regenerative hyperplasia or hyperplasia are types of nonneoplastic proliferative changes that may involve tubular or transitional epithelia. In the rodent kidney, such lesions are almost exclusively associated with CPN, whereas in the bladder they are most often sequelae to crystals, precipitates, or calculi. Metaplasia (squamous, glandular, or mucinous) has also been observed in the transitional epithelium of the renal pelvis or bladder, but is rarely seen in untreated control animals.
CHEMICALLY INDUCED UT TUMORS IN F344 RATS
AND B6C3F 1 MICE According to the NTP Special Report: "Numbers of Chemicals Associated with Site-Speci c Neoplasia," of 35 rodent organs, the kidney ranks second (after liver) as a site for chemically induced neoplasia (data available at <http:// ntp-server.niehs.nih.gov/htdocs/Sites/PSite Cnt.html>, last updated 7/27/00). There is at least some evidence of renal carcinogenicity associated with 57 of 347 chemicals tested by the NTP (Table 6 ). Of these chemicals, 51 have been demonstrated to affect the tubular epithelium, and 9 have been shown to affect the transitional epithelium. In the kidney, the vast majority of chemically induced tumors are derived from tubular or transitional epithelia.
The urinary bladder ranks eleventh as a site for chemically induced tumors. At least some evidence of bladder carcinogenicity exists for 20 of 300 chemicals tested ( Table 7) . Both transitional and squamous epithelial tumors have been produced in the bladders of treated animals, and rare mesenchymal tumors have been observed (caused by C.I. Disperse Blue 1, for example).
Clear evidence of ureteral carcinogenicity has been demonstrated for 2 of 57 chemicals tested. Both of these substances were associated with tumors in rat ureters, and 1 was associated with tumors in the ureters of mice ( Table 8) .
As previously stated, the extent of agreement (concordance) between chronic bioassay results of F344 rats and B6C3F 1 mice is reported to be 74%. In NTP carcinogenicity studies, there is 71% interspecies agreement for the kidney and 65% for the urinary bladder. For each chemical tested, results were considered to be in agreement when there was at least some evidence of carcinogenicity in at least 1 sex of both species, or there was equivocal or no evidence of carcinogenicity in both species.
Chemically induced tumors of the rodent kidney and urinary bladder share certain incidence characteristics with UT tumors that occur spontaneously: rats are affected more commonly than mice; males are affected more than females; the kidney is affected more than the bladder (the opposite of humans); epithelial tumors occur more frequently than tumors of mesenchymal or embryonal origin; and tumors of the renal tubular epithelium are more common than tumors of the renal transitional epithelium.
RATIONALE FOR THE SPECTRUM AND INCIDENCE OF URINARY TRACT TUMORS IN F344 RATS AND B6C3F 1 MICE
Compared to chemicals that induce tumors in other sites, rodent renal and bladder carcinogens are more likely to employ epigenetic (nongenotoxic) mechanisms of tumorigenesis (15) . For example, in one review, only 32% of 59 rodent kidney carcinogens were mutagenic in the Salmonella typhimurium assay (Ames test) (32) . Similarly, based upon NTP data, results of other tests for genotoxicity (eg, sister chromatid exchanges, chromosomal aberrations, bone marrow micronuclei) are often negative for urinary tract carcinogens. Some general characteristics of nongenotoxic carcinogens include long dosing regimes, low tumor incidences, long latency periods, few preneoplastic lesions, sexual dimorphism, rare metastases, a predominance of epithelial (vs mesenchymal) tumors, and links to nonneoplastic conditions (eg, CPN, urolithiasis) (15) . Based upon NTP data, many of these characteristics apply to chemically induced urinary tract carcinogens.
SUMMARY
The male F344 rat appears to be a comparatively sensitive model for chemically induced kidney carcinogenesis. This conclusion is based upon the low spontaneous incidence of primary renal tumors in male rats, and the ability of the male rat kidney to produce tumors in response to a wide variety of chemical carcinogens. In contrast, the female B6C3F 1 mouse seems relatively resistant to both spontaneous and chemically induced urinary tract tumors. The implications of this latter statement for chronic bioassay studies involving the urinary tract are twofold: 1) Negative results in female B6C3F 1 mice do not indicate that the test compound lacks carcinogenic potential, and 2) Positive results are probably biologically signi cant, and suggest a genotoxic mechanism of tumorigenesis.
Many rodent renal and bladder carcinogens rely upon epigenetic mechanisms of carcinogenesis; such mechanisms are likely to in uence the spectrum of urinary tract tumors observed in control and treated animals. This is re ected in several features of chemically induced rodent urinary tract neoplasms, including a low overall tumor incidence, an increased prevalence of UT tumors in rats compared to mice and males compared to females, the tendency for epithelial tumors to predominate over nonepithelial types, and demonstrated links to CPN and urolithiasis. The nongenotoxic nature of many urinary tract carcinogens further indicates that caution must be applied when results of chronic rodent bioassay studies are extrapolated to humans.
